Analysis of Inventory
Paying user area
Try for free
Cigna Group pages available for free this week:
- Statement of Comprehensive Income
- Analysis of Solvency Ratios
- Analysis of Short-term (Operating) Activity Ratios
- Analysis of Long-term (Investment) Activity Ratios
- DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
- Analysis of Reportable Segments
- Enterprise Value (EV)
- Capital Asset Pricing Model (CAPM)
- Price to Earnings (P/E) since 2005
- Analysis of Revenues
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Cigna Group for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Inventory Disclosure
Cigna Group, balance sheet: inventory
US$ in millions
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Prescription drugs and medical supplies | |||||||||||
| Inventories |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
- Trend Analysis of Prescription Drugs and Medical Supplies / Inventories
-
The data exhibits a consistent upward trend in the value of prescription drugs and medical supplies, which is identical to the inventories value over the analyzed period from 2020 to 2024.
Starting at US$3,165 million in 2020, the value increased to US$3,722 million in 2021, representing a growth of approximately 17.6%. The upward trend accelerated in subsequent years, reaching US$4,777 million in 2022, a significant rise of about 28.4% from the previous year.
In 2023, a further increase to US$5,645 million was recorded, reflecting a growth rate of around 18.2%, while the latest figure for 2024 shows continued expansion to US$6,692 million, which is an 18.5% increase compared to 2023.
Overall, the data indicates strong and steady growth in the inventories, specifically prescription drugs and medical supplies, over the five-year period. The consistent rise suggests increasing investment or accumulation in these assets, potentially aligned with business expansion, rising demand, or strategic stockpiling.